Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinmeng Jasmine Mu

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Plos Computational Biology|December 7, 2011
Genomics and privacy: implications of the new reality of closed data for the fieldDov Greenbaum, Andrea Sboner, Xinmeng Jasmine Mu, et al.
Genome Biology|August 27, 2011
The real cost of sequencing: higher than you think!Andrea Sboner, Xinmeng Jasmine Mu, Dov Greenbaum, et al.
NPJ Precision Oncology|July 31, 2025
Identification of breast cancer subtypes and drug response prediction through forward and reverse translationJulie Karam, Paul A Rejto, Jadwiga Renata Bienkowska, et al.
Nucleic Acids Research|May 21, 2011
Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes ProjectXinmeng Jasmine Mu, Zhi John Lu, Yong Kong, et al.
The Journal of Biological Chemistry|September 2, 2008
Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replicationNicole E Pagliaccetti, Roger Eduardo, Steven H Kleinstein, et al.
Genome Biology|October 3, 2014
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancerYao Fu, Zhu Liu, Shaoke Lou, et al.
Genome Biology|February 25, 2009
PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing dataJan O Korbel, Alexej Abyzov, Xinmeng Jasmine Mu, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2021
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancerAndrew J Armstrong, Xiaotong Li, Matthew Tucker, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Photoproximity labeling of c-Myc reveals SLK as a cancer specific co-regulatorRyan R Milione, Feifei Tong, Kelsey L Wolfe, et al.
Nature Biotechnology|December 29, 2009
Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint libraryHugo Y K Lam, Xinmeng Jasmine Mu, Adrian M Stütz, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Plos Computational Biology|December 7, 2011
Genomics and privacy: implications of the new reality of closed data for the fieldDov Greenbaum, Andrea Sboner, Xinmeng Jasmine Mu, et al.
Genome Biology|August 27, 2011
The real cost of sequencing: higher than you think!Andrea Sboner, Xinmeng Jasmine Mu, Dov Greenbaum, et al.
NPJ Precision Oncology|July 31, 2025
Identification of breast cancer subtypes and drug response prediction through forward and reverse translationJulie Karam, Paul A Rejto, Jadwiga Renata Bienkowska, et al.
Nucleic Acids Research|May 21, 2011
Analysis of genomic variation in non-coding elements using population-scale sequencing data from the 1000 Genomes ProjectXinmeng Jasmine Mu, Zhi John Lu, Yong Kong, et al.
The Journal of Biological Chemistry|September 2, 2008
Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replicationNicole E Pagliaccetti, Roger Eduardo, Steven H Kleinstein, et al.
Genome Biology|October 3, 2014
FunSeq2: a framework for prioritizing noncoding regulatory variants in cancerYao Fu, Zhu Liu, Shaoke Lou, et al.
Genome Biology|February 25, 2009
PEMer: a computational framework with simulation-based error models for inferring genomic structural variants from massive paired-end sequencing dataJan O Korbel, Alexej Abyzov, Xinmeng Jasmine Mu, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2021
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancerAndrew J Armstrong, Xiaotong Li, Matthew Tucker, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Photoproximity labeling of c-Myc reveals SLK as a cancer specific co-regulatorRyan R Milione, Feifei Tong, Kelsey L Wolfe, et al.
Nature Biotechnology|December 29, 2009
Nucleotide-resolution analysis of structural variants using BreakSeq and a breakpoint libraryHugo Y K Lam, Xinmeng Jasmine Mu, Adrian M Stütz, et al.
Pageof 4